CEAT Faces ₹ 3.06 Lakh Penalty for Delay in Re-export Extension Application

CEAT Faces ₹ 3.06 Lakh Penalty for Delay in Re-export Extension Application

The copy of the communication from the Authority was received by the Officers of the Company as defined under Companies Act, 2023 on September 12, 2023.

FPJ Web DeskUpdated: Wednesday, September 13, 2023, 01:37 PM IST
article-image
CEAT Faces ₹ 3.06 Lakh Penalty for Delay in Re-export Extension Application | Wikipedia

CEAT Limited on Wednesday announced that the Office of Commissioner of Customs, (NS – III), Raigad, Maharashtra has imposed penalty of Rs 3,06,000 under section 117 of Customs Act, 1962 for delay in application for permission of re-export extension against the Bills of Entries, the company on Wednesday announced through an exchange filing.

The copy of the communication from the Authority was received by the Officers of the Company as defined under Companies Act, 2023 on September 12, 2023.

The company on the filing said that based on the Company’s assessment, the Company is of the opinion that there is no major impact of the penalty on the financials of the Company.

CEAT Limited shares

The shares of CEAT Limited on Wednesday at 1:27 pm IST were at Rs 2,135, down by 0.80 percent.

CEAT Limited Q1FY24 Highlights

On a consolidated basis, the Company’s revenue closed at ₹2,935 crore, EBITDA margin stood at 13.1 percent. Net profit stood at ₹144 crore.

On a standalone basis, the Company’s revenue stood at ₹2,921 crore and EBITDA margin stood at 13.2 percent. Net profit stood at ₹159 crore.

RECENT STORIES

Adani Group To Invest US Dollar 75 Billion To Scale Up AGEL's RE Portfolio To 45 GW: Gautam Adani

Adani Group To Invest US Dollar 75 Billion To Scale Up AGEL's RE Portfolio To 45 GW: Gautam Adani

Closing Bell: Indices End At Record High; Sensex At 69,653.73, Nifty At 20,937.70

Closing Bell: Indices End At Record High; Sensex At 69,653.73, Nifty At 20,937.70

Indoco Remedies Receives Tentative ANDA Approval From USFDA For Canagliflozin Tablets

Indoco Remedies Receives Tentative ANDA Approval From USFDA For Canagliflozin Tablets

Zydus Receives Final Approval From The USFDA For Methylene Blue Injection

Zydus Receives Final Approval From The USFDA For Methylene Blue Injection

Full List Of The Top 10 Largest Economies In The World In 2023

Full List Of The Top 10 Largest Economies In The World In 2023